Sarepta DMD Treatment Improves Motor Skills in Study Presented at JPM

Sarepta DMD Treatment Improves Motor Skills in Study Presented at JPM

Submitted by admin on January 11, 2022 - 11:41am
Source: 
BioSpace
News Tags: 
Sarepta Therapeutics
delandistrogene moxeparvovec
Duchenne Muscular Dystrophy
JPMHC 2022
Headline: 
Sarepta DMD Treatment Improves Motor Skills in Study Presented at JPM
snippet: 

Sarepta Therapeutics shared positive topline results from its ongoing SRP-9001-102 study (Study 102) on the effectiveness of delandistrogene moxeparvovec in treating Duchenne muscular dystrophy (DMD).

Do Not Allow Advertisers to Use My Personal information